Advances in oral peptide drug nanoparticles for diabetes mellitus treatment.
Quick Facts
What This Study Found
Nanoparticles can significantly improve the oral bioavailability of peptide drugs.
Key Numbers
How They Did This
This is a review study that analyzes existing research on nanoparticles for oral peptide drug delivery.
Why This Research Matters
Improving the oral delivery of peptide drugs could lead to better patient compliance and treatment outcomes for diabetes. This research highlights innovative solutions to a common problem in drug delivery.
What This Study Doesn't Tell Us
As a review, it does not present new experimental data and relies on existing literature, which may vary in quality.
Trust & Context
- Original Title:
- Advances in oral peptide drug nanoparticles for diabetes mellitus treatment.
- Published In:
- Bioactive materials, 15, 392-408 (2022)
- Authors:
- Li, Yan(7), Zhang, Wen(2), Zhao, Ruichen, Zhang, Xin
- Database ID:
- RPEP-06308
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06308APA
Li, Yan; Zhang, Wen; Zhao, Ruichen; Zhang, Xin. (2022). Advances in oral peptide drug nanoparticles for diabetes mellitus treatment.. Bioactive materials, 15, 392-408. https://doi.org/10.1016/j.bioactmat.2022.02.025
MLA
Li, Yan, et al. "Advances in oral peptide drug nanoparticles for diabetes mellitus treatment.." Bioactive materials, 2022. https://doi.org/10.1016/j.bioactmat.2022.02.025
RethinkPeptides
RethinkPeptides Research Database. "Advances in oral peptide drug nanoparticles for diabetes mel..." RPEP-06308. Retrieved from https://rethinkpeptides.com/research/li-2022-advances-in-oral-peptide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.